Antiaritmias gyogyszerek interakcioja a beultetheto defibrillatorral

Translated title of the contribution: Interactions between the implantable defibrillator and antiarrhythmic drugs

A. Pinter, P. Dorian, I. Préda

Research output: Contribution to journalArticle

Abstract

Antiarrhythmic drug therapy in conjunction with implantable defibrillator may be required for various reasons, like limiting the number of VT/VF episodes that require shock delivery, and treating supraventricular arrhythmias. Unfortunately, some of the effects of antiarrhythmic drugs may interfere with the detection or treatment of malignant ventricular arrhythmias by the defibrillator. The potentially beneficial as well as the deleterious interactions are reviewed. Sotatol, amiodarone and beta-blockers are the most frequently used antiarrhythmic drugs in patients with the implantable defibrillator. The advantages and disadvantages of each drug are discussed.

Original languageHungarian
Pages (from-to)76-80
Number of pages5
JournalOrvoskepzes
Volume75
Issue number1-2
Publication statusPublished - 2000

Fingerprint

Implantable Defibrillators
Anti-Arrhythmia Agents
Cardiac Arrhythmias
Defibrillators
Amiodarone
Shock
Drug Therapy
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Antiaritmias gyogyszerek interakcioja a beultetheto defibrillatorral. / Pinter, A.; Dorian, P.; Préda, I.

In: Orvoskepzes, Vol. 75, No. 1-2, 2000, p. 76-80.

Research output: Contribution to journalArticle

Pinter, A, Dorian, P & Préda, I 2000, 'Antiaritmias gyogyszerek interakcioja a beultetheto defibrillatorral', Orvoskepzes, vol. 75, no. 1-2, pp. 76-80.
Pinter, A. ; Dorian, P. ; Préda, I. / Antiaritmias gyogyszerek interakcioja a beultetheto defibrillatorral. In: Orvoskepzes. 2000 ; Vol. 75, No. 1-2. pp. 76-80.
@article{998ba068973c47c4a6eb4411cb1835bc,
title = "Antiaritmias gyogyszerek interakcioja a beultetheto defibrillatorral",
abstract = "Antiarrhythmic drug therapy in conjunction with implantable defibrillator may be required for various reasons, like limiting the number of VT/VF episodes that require shock delivery, and treating supraventricular arrhythmias. Unfortunately, some of the effects of antiarrhythmic drugs may interfere with the detection or treatment of malignant ventricular arrhythmias by the defibrillator. The potentially beneficial as well as the deleterious interactions are reviewed. Sotatol, amiodarone and beta-blockers are the most frequently used antiarrhythmic drugs in patients with the implantable defibrillator. The advantages and disadvantages of each drug are discussed.",
author = "A. Pinter and P. Dorian and I. Pr{\'e}da",
year = "2000",
language = "Hungarian",
volume = "75",
pages = "76--80",
journal = "Orvoskepzes",
issn = "0030-6037",
publisher = "Semmelweis Kiado",
number = "1-2",

}

TY - JOUR

T1 - Antiaritmias gyogyszerek interakcioja a beultetheto defibrillatorral

AU - Pinter, A.

AU - Dorian, P.

AU - Préda, I.

PY - 2000

Y1 - 2000

N2 - Antiarrhythmic drug therapy in conjunction with implantable defibrillator may be required for various reasons, like limiting the number of VT/VF episodes that require shock delivery, and treating supraventricular arrhythmias. Unfortunately, some of the effects of antiarrhythmic drugs may interfere with the detection or treatment of malignant ventricular arrhythmias by the defibrillator. The potentially beneficial as well as the deleterious interactions are reviewed. Sotatol, amiodarone and beta-blockers are the most frequently used antiarrhythmic drugs in patients with the implantable defibrillator. The advantages and disadvantages of each drug are discussed.

AB - Antiarrhythmic drug therapy in conjunction with implantable defibrillator may be required for various reasons, like limiting the number of VT/VF episodes that require shock delivery, and treating supraventricular arrhythmias. Unfortunately, some of the effects of antiarrhythmic drugs may interfere with the detection or treatment of malignant ventricular arrhythmias by the defibrillator. The potentially beneficial as well as the deleterious interactions are reviewed. Sotatol, amiodarone and beta-blockers are the most frequently used antiarrhythmic drugs in patients with the implantable defibrillator. The advantages and disadvantages of each drug are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0033767933&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033767933&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0033767933

VL - 75

SP - 76

EP - 80

JO - Orvoskepzes

JF - Orvoskepzes

SN - 0030-6037

IS - 1-2

ER -